Current status: 1123 hESC lines, 7722 hiPSC lines, and 205 clinical studies, and 2402 certificates
Monthly statistic from Mar 1, 2026
Posted on March 1, 2026
| total lines | 8845 |
| hESC lines | 1123 |
| hiPSC lines | 7722 |
| derivation countries | 52 |
| projects | 336 |
| providers | 1037 |
| clinical studies | 205 |
| subclones | 3968 |
| certificates | 2402 |
| cell line certificates | 2247 |
| project certificates | 155 |